133 related articles for article (PubMed ID: 37739924)
21. Malignant Transformation of Mature Cystic Teratoma: Is Squamous Cell Carcinoma Different From the Other Types of Neoplasm?
Akazawa M; Onjo S
Int J Gynecol Cancer; 2018 Nov; 28(9):1650-1656. PubMed ID: 30358706
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis.
Hirakawa T; Tsuneyoshi M; Enjoji M
Am J Surg Pathol; 1989 May; 13(5):397-405. PubMed ID: 2712191
[TBL] [Abstract][Full Text] [Related]
23. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature.
Dos Santos L; Mok E; Iasonos A; Park K; Soslow RA; Aghajanian C; Alektiar K; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2007 May; 105(2):321-4. PubMed ID: 17240432
[TBL] [Abstract][Full Text] [Related]
25. Relevance of frozen sections and serum markers in invasive squamous cell carcinoma arising from ovarian mature cystic teratoma: two case reports.
Tazo Y; Yoshimura Y; Shoda T; Kyushima N; Okada T; Yamazaki H
J Med Case Rep; 2016 Jan; 10():20. PubMed ID: 26801904
[TBL] [Abstract][Full Text] [Related]
26. Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.
Liu J; Li Z; Lu T; Pan J; Li L; Song Y; Hu D; Zhuo Y; Chen Y; Xu Q
BMC Med Genomics; 2022 Nov; 15(1):231. PubMed ID: 36333792
[TBL] [Abstract][Full Text] [Related]
27. The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.
Zhou F; Huang Y; Cai W; Li J; Su C; Ren S; Wu C; Zhou C
Lung Cancer; 2021 Mar; 153():66-72. PubMed ID: 33454519
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: an immunohistochemical analysis of its tumorigenesis.
Iwasa A; Oda Y; Kaneki E; Ohishi Y; Kurihara S; Yamada T; Hirakawa T; Wake N; Tsuneyoshi M
Histopathology; 2007 Jul; 51(1):98-104. PubMed ID: 17542994
[TBL] [Abstract][Full Text] [Related]
29. Malignant tumors associated with ovarian mature teratoma: A single institution experience.
Trabzonlu L; Durmaz G; Vural C; Muezzinoglu B; Corakci A
Pathol Res Pract; 2017 May; 213(5):518-521. PubMed ID: 28214217
[TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report.
Yano M; Asami Y; Nishikawa T; Yoshida S; Kamada K; Katoh T; Teramoto Y; Nakamura Y; Yasuda M
Medicine (Baltimore); 2018 Oct; 97(43):e12937. PubMed ID: 30412106
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.
Gadducci A; Giuliani D; Cosio S; Lissoni A; Ferrero AM; Landoni F
Anticancer Res; 2019 May; 39(5):2513-2517. PubMed ID: 31092447
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
Yoshioka T; Tanaka T
J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
34. Esophageal squamous cell carcinoma with basaloid features are genetically and prognostically similar to conventional squamous cell carcinoma.
Sauer MA; Yang J; Isidro RA; Dong F; Patil DT; Wee JO; Agoston AT; Deshpande V; Zhao L
Mod Pathol; 2022 Sep; 35(9):1247-1253. PubMed ID: 35351978
[TBL] [Abstract][Full Text] [Related]
35. The evolution of mature cystic teratomas of the ovary into squamous cell carcinoma: two case reports and review of the literature.
Ziadeh H; Duforestel T; Bouredji K; Re D; Debono L; Zreik T; Moufawad G; Ghaname W
J Obstet Gynaecol; 2022 Jul; 42(5):838-841. PubMed ID: 35225134
[TBL] [Abstract][Full Text] [Related]
36. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
[TBL] [Abstract][Full Text] [Related]
37. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
38. Malignant transformation of mature cystic teratoma of the ovary: 30-year experience of a single tertiary care center.
Al Wazzan A; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
Eur J Gynaecol Oncol; 2016; 37(6):809-813. PubMed ID: 29943926
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
[TBL] [Abstract][Full Text] [Related]
40. Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.
D'Angelo E; Espinosa I; Felicioni L; Buttitta F; Prat J
Hum Pathol; 2023 Nov; 141():15-21. PubMed ID: 37673346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
